PET/CT enhances care for lung cancer patients

July 9, 2013

PET/CT improves staging accuracy and intrathoracic disease identification, which can lead to improved clinical outcomes for patients with limited-stage small-cell lung cancer (LS-SCLC), according to a study published in the July issue of the Journal of Thoracic Oncology.

Researchers led by Dr. Eric Xanthopoulos, a radiation oncology intern at the University of Pennsylvania, found that pretreatment PET staging of limited-stage small-cell lung cancer was associated with improved survival.